3 Stocks Under $10 to Buy in May

The article highlights three sub-$10 stocks it views as attractive: Archer Aviation, Snap, and StubHub, citing Archer's projected revenue ramp from $14 million in 2026 to $1.6 billion in 2029, Snap's 956 million monthly active users and 12% latest-quarter revenue growth, and StubHub trading at 6x next year's projected earnings. StubHub remains the riskiest name due to legal and business-model concerns, including a 1% revenue decline last year and regulatory pressure on ticket resale markups. Overall, the piece is a bullish stock-picking commentary rather than a company-specific catalyst.

Analysis

The market is pricing these names as if the distribution of outcomes is still extremely wide, but the dispersion is not symmetric. ACHR has the cleanest optionality because any credible certification or commercial milestone can re-rate it well before material revenue arrives; the stock is effectively a long-duration call on regulatory de-risking. That said, the valuation gap versus its closest peer can persist for quarters if the market keeps assigning a higher probability to delay rather than scale, so the trade is more about timing catalysts than fundamental earnings power.

SNAP is the more interesting business-quality setup because it is moving from “growth at any cost” toward a cash-generative ad platform, and that tends to support multiple expansion even if revenue growth stays mid-teens or lower. The second-order effect is that improving ARPU and engagement make the company less dependent on a single ad-cycle rebound; if ad budgets remain selective, Snap can still win share from smaller social and gaming ad channels that lack its measurement and creative tooling. The main risk is that investors overestimate the durability of margin improvement if platform partners or privacy changes compress ad yields again.

STUB is the most fragile and arguably the most mispriced if you believe the legal overhang is bounded, because the market is already discounting a material impairment to the business model. The issue is not just headline litigation; it is that regulatory precedent can cascade into pricing rules, which would attack the take-rate structure rather than just add one-off fines. If the anti-resale framework spreads, this becomes a structurally smaller TAM story, and the current multiple is not cheap enough to compensate for that tail risk.

The clearest contrarian point is that the obvious winner/loser map may be wrong in order of magnitude: JOBY may look weaker near term, but relative execution risk and valuation discipline could make it the better expression if both eVTOL names take longer than expected. Conversely, LYV’s legal setback is a medium-horizon threat, not an immediate earnings hit, so the stock may be less impaired than the market fears if remedies are delayed or narrow.

Key Decisions for Investors

• Long ACHR vs. short JOBY in a 3-6 month pair trade: own the higher perceived milestone credibility while hedging sector beta; target 20-30% relative upside if Archer continues to win incremental de-risking headlines.
• Buy SNAP on a 6-12 month horizon via stock or call spreads: the setup is a re-rating trade on cash flow and ad efficiency, with downside cushioned by positive free cash flow and upside from multiple normalization.
• Avoid outright long STUB until legal clarity improves; if forced to express the view, use a limited-risk bearish structure such as put spreads over 3-6 months because the model risk is binary and valuation support is weak.
• Consider a hedged long LYV position only if you want exposure to live-event demand: pair it against STUB to isolate platform/take-rate risk, since the litigation overhang is more likely to hit the marketplace intermediary than the venue/ownership chain.
• For ACHR, wait for a pullback into catalyst windows rather than chasing strength; the stock is a volatility instrument, so entry discipline matters more than valuation.